These results determine a diagnosis accuracy of 90.27%, which allows us to propose the cGCSC (CD24+CD44+CD54+EpCAM+) evaluation as a potential noninvasive diagnostic or screening test for GC. The gene discussed is EPCAM; the disease is gastric cancer.